Volume 10, Number 6—June 2004
Letter
CTX-M and Plasmid-mediated AmpC-Producing Enterobacteriaceae, Singapore
Tse Hsien Koh*
, Grace Chee Yeng Wang*, Li-Hwei Sng*, Zhao Yi*, and Tse Yuen Koh†
, Grace Chee Yeng Wang*, Li-Hwei Sng*, Zhao Yi*, and Tse Yuen Koh†
Table
Characteristics of isolates containing CTX-M and plasmid-mediated AmpC β-lactamases
| Isolate | Species | MIC (μg/mL)a |
pIb | Sequenced β-lactamase | |||
|---|---|---|---|---|---|---|---|
| CAZ | FEP | CRO | AZT | ||||
| EU17113 |
K. pneumoniae |
4 |
4 |
128 |
2 |
7.2, 7.5, 8.0 |
CTX-M-9 type |
| EU2673 |
K. pneumoniae |
128 |
128 |
>256 |
>256 |
5.8, 7.2, 7.5, 9.0 |
CTX-M-15 type |
| EU2657 |
E. coli |
16 |
128 |
>256 |
64 |
5.1, 6.3, 7.2, 7.5, 8.0 |
CTX-M-2 type |
| EU4855 |
E. coli |
>256 |
4 |
>256 |
64 |
8.8 |
CMY-2 type |
| EB9505 | E. coli | 128 | 1 | 256 | 8 | 5.1, 8.8 | CMY-2 type |
aK. pneumoniae, Klebsiella pneumoniae; E. coli, Escherichia coli; CAZ, ceftazidime; FEP, cefepime; CRO, ceftriaxone; AZT, aztreonam.
bIsoelectric points of β-lactamases.
Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.